AbbVie
ABBV
1,457 hedge funds and large institutions have $63.8B invested in AbbVie in 2014 Q2 according to their latest regulatory filings, with 99 funds opening new positions, 551 increasing their positions, 593 reducing their positions, and 56 closing their positions.
77% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 56
60% more call options, than puts
Call options by funds: $308M | Put options by funds: $193M
35% more funds holding in top 10
Funds holding in top 10: 51 → 69 (+18)
13% more capital invested
Capital invested by funds: $56.6B → $63.8B (+$7.23B)
2% more funds holding
Funds holding: 1,422 → 1,457 (+35)
2.13% more ownership
Funds ownership: 68.97% → 71.1% (+2.1%)
7% less repeat investments, than reductions
Existing positions increased: 551 | Existing positions reduced: 593
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$613M |
| 2 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$329M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
+$170M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$151M |
| 5 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$141M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$636M |
| 2 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$132M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$127M |
| 4 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$115M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
-$114M |
ABBV Hedge Fund Activity: Q2 2014 in Review
1,457 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2014, worth a combined $63.8B — up 13% from $56.6B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new ABBV positions and 56 closed out — a net gain of 43 holders — while 551 added to existing stakes and 593 trimmed.
The largest buyer was Norges Bank, adding an estimated $613M. The largest seller was Fidelity Investments, cutting an estimated $636M.
- 1,457 institutional investors held AbbVie (ABBV) as of Q2 2014, up from 1,422 in Q1 2014.
- Funds reported $63.8B of AbbVie stock for Q2 2014, up 13% quarter-over-quarter.
- 99 funds opened new AbbVie positions in Q2 2014 and 56 closed out, a net change of +43 holders.
- The largest AbbVie buyer in Q2 2014 was Norges Bank, an estimated $613M added.
- The largest AbbVie seller in Q2 2014 was Fidelity Investments, an estimated $636M sold.
Based on aggregated 13F filings for Q2 2014.